Top Markets
#1 ICON ICON +96.71%
#2 ZetaChain ZetaChain +46.56%
#3 Four Four +45.47%
#4 Mubarak Mubarak +33.83%
#5 World Mobile Token World Mobile Token +32.84%
#6 Phala Phala +32.67%
#7 Bitway Bitway +25.20%
#8 PumpMeme PumpMeme +24.26%
#9 The Innovation Game The Innovation Game +24.19%
#10 Pepe Pepe +23.25%
Coin of the day
ICON ICON
Settings
Language
ENGLISH
Currency
USD
Theme
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Rank in Stocks #832
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Share Price
$71.25
Market Cap
$29.87B
Change (1 day)
-0.34%
Change (1 year)
-51.16%
Country
US
Trade Zoetis Inc. (ZTS)

Category

Healthcare
Number of shares outstanding for Zoetis Inc. (ZTS)
Number of shares outstanding as of June 2026: 417.60M
According to Zoetis Inc. latest financial reports and stock price the company's current number of shares outstanding is 417.60M. At the end of December 2024 the company had 454.20M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Zoetis Inc. (ZTS) from 2009 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 417.60M -5.83%
2025 443.44M -2.37%
2024 454.20M -1.51%
2023 461.17M -1.65%
2022 468.89M -1.15%
2021 474.35M -0.24%
2020 475.50M -0.55%
2019 478.13M -1.02%
2018 483.06M -1.40%
2017 489.92M -1.17%
2016 495.72M -0.80%
2015 499.71M -0.27%
2014 501.06M 0.21%
2013 500.00M 0.00%
2012 500.00M 4.57%
2011 478.13M 0.00%
2010 478.13M 0.00%
2009 478.13M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 113.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 484.33%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 324.09%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 90.61%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US